Jump to content
  • Posts

  • Joined

  • Last visited




3 Novice

Profile Information

  • First name
  • Last name
  • Country
    United Kingdom

About me

  • About me
    I am a independent consultant on safe medication practice and patient safety. I am an advisor to the charity Action Against Medical Accidents
  • Organisation
  • Role
    Safe Medication Practice Consultant

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Community Post
    Over the pandemic the topic of greater use of prefilled syringes and other ready to administer medicines especially in critical care areas was highlighted. The European Association of Hospital Pharmacists have set up a special interest to review this area of practice. I am a member of the special interest group and we are very interested to receive the view of critical care nurses on this topic. Ther is a short survey for nursers to complete - please complete by 9th November 2022 to help inform our work on this topic. See link below. https://www.surveymonkey.com/r/PFSenglish2
  2. Community Post
    I think this topic of how the measures taken for COVID are impacting on the safe treatment of other medical conditions is very important. NHS England have published treatment guidance on how a wide range of medical conditions should be priortised and treated during the Covid pandemic - see link below https://www.england.nhs.uk/coronavirus/secondary-care/other-resources/specialty-guides/ NICE has also issued guidance and more is on the way. https://www.nice.org.uk/covid-19 Ths guidance may introduce new risks and increase other known risks. Is this guidance being followed in practice or are patients treatment being impacted when local guidance and priorities are being introduced?
  3. Content Article Comment
    Thank you for sharing your response to the AvMA report. In your organisations’ Blueprint for Action’, you highlight data and insight for patient safety as one of the six foundations of safe care. You recommend health and social care system to develop models for measuring, reporting and assessing patient safety performance to identify and address shortfalls in performance. These recommendation is very similar to those included in the AvMA report. You ask the question whether the National Patient Safety Alerting Committee (NaPSAC) might be best placed to perform this role. This body’s core purpose is to ‘agree progress and oversee systems that will clearly identify which nationally-issued patient safety advice and guidance is safety-critical’ This could be a role for the committee, but only after it’s remit and that of the Patient Safety Team at NHS Improvement have been clarified to once again include known/wicked risks previously identified in patient safety alerts, and more detailed information about all major risks identified from reports to the NRLS is again shared openly.